Tarsus Pharmaceuticalsinc Stock Volatility
| TARS Stock | USD 32.85 1.57 4.56% |
Tarsus PharmaceuticalsI appears to be not too volatile, given 3 months investment horizon. Tarsus PharmaceuticalsInc owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Tarsus PharmaceuticalsInc, which you can use to evaluate the volatility of the company. Please review Tarsus PharmaceuticalsI's Risk Adjusted Performance of 0.1042, coefficient of variation of 645.75, and Semi Deviation of 2.71 to confirm if our risk estimates are consistent with your expectations. Key indicators related to Tarsus PharmaceuticalsI's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Tarsus PharmaceuticalsI Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Tarsus daily returns, and it is calculated using variance and standard deviation. We also use Tarsus's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Tarsus PharmaceuticalsI volatility.
Tarsus |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Tarsus PharmaceuticalsI can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Tarsus PharmaceuticalsI at lower prices. For example, an investor can purchase Tarsus stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Tarsus PharmaceuticalsI's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Tarsus Stock
| 0.61 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.69 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
| 0.71 | VANI | Vivani Medical | PairCorr |
Moving against Tarsus Stock
| 0.75 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.7 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.68 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
| 0.6 | ME | 23Andme Holding | PairCorr |
| 0.6 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.59 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.54 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
| 0.54 | DRTS | Alpha Tau Medical Financial Report 28th of May 2024 | PairCorr |
| 0.52 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
Tarsus PharmaceuticalsI Market Sensitivity And Downside Risk
Tarsus PharmaceuticalsI's beta coefficient measures the volatility of Tarsus stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Tarsus stock's returns against your selected market. In other words, Tarsus PharmaceuticalsI's beta of 2.63 provides an investor with an approximation of how much risk Tarsus PharmaceuticalsI stock can potentially add to one of your existing portfolios. Tarsus PharmaceuticalsInc shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Tarsus PharmaceuticalsI's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Tarsus PharmaceuticalsI's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Tarsus PharmaceuticalsInc Demand TrendCheck current 90 days Tarsus PharmaceuticalsI correlation with market (NYSE Composite)Tarsus Beta |
Tarsus standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.16 |
It is essential to understand the difference between upside risk (as represented by Tarsus PharmaceuticalsI's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Tarsus PharmaceuticalsI's daily returns or price. Since the actual investment returns on holding a position in tarsus stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Tarsus PharmaceuticalsI.
Using Tarsus Put Option to Manage Risk
Put options written on Tarsus PharmaceuticalsI grant holders of the option the right to sell a specified amount of Tarsus PharmaceuticalsI at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Tarsus Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Tarsus PharmaceuticalsI's position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Tarsus PharmaceuticalsI will be realized, the loss incurred will be offset by the profits made with the option trade.
Tarsus PharmaceuticalsI's PUT expiring on 2024-04-19
Profit |
| Tarsus PharmaceuticalsI Price At Expiration |
Current Tarsus PharmaceuticalsI Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-04-19 PUT at $45.0 | -0.7069 | 0.028 | 1 | 2024-04-19 | 7.5 - 12.0 | 9.0 | View |
Put | 2024-04-19 PUT at $40.0 | -0.6484 | 0.0401 | 1 | 2024-04-19 | 2.5 - 7.0 | 11.2 | View |
Tarsus PharmaceuticalsInc Stock Volatility Analysis
Volatility refers to the frequency at which Tarsus PharmaceuticalsI stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Tarsus PharmaceuticalsI's price changes. Investors will then calculate the volatility of Tarsus PharmaceuticalsI's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Tarsus PharmaceuticalsI's volatility:
Historical Volatility
This type of stock volatility measures Tarsus PharmaceuticalsI's fluctuations based on previous trends. It's commonly used to predict Tarsus PharmaceuticalsI's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Tarsus PharmaceuticalsI's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Tarsus PharmaceuticalsI's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Tarsus PharmaceuticalsInc Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Tarsus PharmaceuticalsI Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 2.631 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Tarsus PharmaceuticalsI will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Tarsus PharmaceuticalsI or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Tarsus PharmaceuticalsI's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Tarsus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Tarsus PharmaceuticalsInc has an alpha of 0.4879, implying that it can generate a 0.49 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Tarsus PharmaceuticalsI Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Tarsus PharmaceuticalsI Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Tarsus PharmaceuticalsI is 844.44. The daily returns are distributed with a variance of 17.3 and standard deviation of 4.16. The mean deviation of Tarsus PharmaceuticalsInc is currently at 2.97. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α | Alpha over NYSE Composite | 0.49 | |
β | Beta against NYSE Composite | 2.63 | |
σ | Overall volatility | 4.16 | |
Ir | Information ratio | 0.14 |
Tarsus PharmaceuticalsI Stock Return Volatility
Tarsus PharmaceuticalsI historical daily return volatility represents how much of Tarsus PharmaceuticalsI stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 4.1596% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6214% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Tarsus PharmaceuticalsI Volatility
Volatility is a rate at which the price of Tarsus PharmaceuticalsI or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Tarsus PharmaceuticalsI may increase or decrease. In other words, similar to Tarsus's beta indicator, it measures the risk of Tarsus PharmaceuticalsI and helps estimate the fluctuations that may happen in a short period of time. So if prices of Tarsus PharmaceuticalsI fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 756 M | 793.8 M |
Tarsus PharmaceuticalsI's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Tarsus Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Tarsus PharmaceuticalsI's price varies over time.
3 ways to utilize Tarsus PharmaceuticalsI's volatility to invest better
Higher Tarsus PharmaceuticalsI's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Tarsus PharmaceuticalsInc stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Tarsus PharmaceuticalsInc stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Tarsus PharmaceuticalsInc investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Tarsus PharmaceuticalsI's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Tarsus PharmaceuticalsI's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Tarsus PharmaceuticalsI Investment Opportunity
Tarsus PharmaceuticalsInc has a volatility of 4.16 and is 6.71 times more volatile than NYSE Composite. Compared to the overall equity markets, volatility of historical daily returns of Tarsus PharmaceuticalsInc is lower than 36 percent of all global equities and portfolios over the last 90 days. You can use Tarsus PharmaceuticalsInc to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of Tarsus PharmaceuticalsI to be traded at $31.21 in 90 days.Weak diversification
The correlation between Tarsus PharmaceuticalsInc and NYA is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus PharmaceuticalsInc and NYA in the same portfolio, assuming nothing else is changed.
Tarsus PharmaceuticalsI Additional Risk Indicators
The analysis of Tarsus PharmaceuticalsI's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Tarsus PharmaceuticalsI's investment and either accepting that risk or mitigating it. Along with some common measures of Tarsus PharmaceuticalsI stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1042 | |||
| Market Risk Adjusted Performance | 0.254 | |||
| Mean Deviation | 3.1 | |||
| Semi Deviation | 2.71 | |||
| Downside Deviation | 3.03 | |||
| Coefficient Of Variation | 645.75 | |||
| Standard Deviation | 4.21 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Tarsus PharmaceuticalsI Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Tarsus PharmaceuticalsI as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Tarsus PharmaceuticalsI's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Tarsus PharmaceuticalsI's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Tarsus PharmaceuticalsInc.
When determining whether Tarsus PharmaceuticalsInc is a strong investment it is important to analyze Tarsus PharmaceuticalsI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tarsus PharmaceuticalsI's future performance. For an informed investment choice regarding Tarsus Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tarsus PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Tarsus Stock analysis
When running Tarsus PharmaceuticalsI's price analysis, check to measure Tarsus PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus PharmaceuticalsI is operating at the current time. Most of Tarsus PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Tarsus PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Tarsus PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Tarsus PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tarsus PharmaceuticalsI. If investors know Tarsus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tarsus PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.62) | Revenue Per Share 0.594 | Quarterly Revenue Growth 0.308 | Return On Assets (0.36) | Return On Equity (0.70) |
The market value of Tarsus PharmaceuticalsInc is measured differently than its book value, which is the value of Tarsus that is recorded on the company's balance sheet. Investors also form their own opinion of Tarsus PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Tarsus PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tarsus PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Tarsus PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tarsus PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tarsus PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tarsus PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.